Risk factors for pathologic gambling and other compulsions among Parkinson’s disease patients taking dopamine agonists
Authors:
- Geetha KandimalaGKGeetha Kandimala
- Richard B. DeweyRDRichard B. Dewey
- Padraig O’sUilleabhainPOPadraig O’sUilleabhain
- 1 December 2007
- journal article
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 14 (12) , 1178-1181
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Clinical features associated with impulse control disorders in Parkinson diseaseNeurology, 2006
- Association of Dopamine Agonist Use With Impulse Control Disorders in Parkinson DiseaseArchives of Neurology, 2006
- Prospective prevalence of pathologic gambling and medication association in Parkinson diseaseNeurology, 2006
- Association Between Pathologic Gambling and Parkinsonian Therapy as Detected in the Food and Drug Administration Adverse Event DatabaseArchives of Neurology, 2006
- Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson's disease: A review of the literatureClinical Therapeutics, 2006
- Pathological Gambling Caused by Drugs Used to Treat Parkinson DiseaseArchives of Neurology, 2005
- Pathological gambling associated with dopamine agonist therapy in Parkinson’s diseaseNeurology, 2003
- SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disordersMovement Disorders, 2003
- Pathological gambling behaviour: Emergence secondary to treatment of Parkinson's disease with dopaminergic agentsDepression and Anxiety, 2000
- Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis.American Journal of Public Health, 1999